News

Better understanding of environmentally triggered diseases

The interplay of genetics and epigenetics is a long-sought riddle in the development of diseases. Researchers from Helmholtz Munich and the Imperial…

Read more
Prof. Stefan Engelhardt and startup rnatics develop an RNA-based drug that can prevent inflammatory lung conditions associated with Covid-19. Image: Andreas Heddergott / TUM

A spray to protect against lung damage from Covid-19

A research team led by Stefan Engelhardt, Professor of Pharmacology and Toxicology at the Technical University of Munich (TUM) and Principal…

Read more

Healthy muscle can protect the heart

Musclin, a hormone-like messenger substance of the skeletal muscle, protects against the pathological overload of the heart. For patients with chronic…

Read more

Even a mild course of COVID-19 leaves traces on organs​

Even mild disease courses with COVID-19 impair the heart, lungs and kidneys. Scientists from the Hamburg University Medical Center Hamburg-Eppendorf…

Read more

Special evaluations safeguard decisions in heart valve replacement

The German Center for Cardiovascular Research (DZHK) is funding several special evaluations of the German Aortic Valve Registry (GARY). The results…

Read more

Cardiovascular science provided the blueprint for university Covid-19 research

The German Center for Cardiovascular Research has carried out pioneering clinical Covid-19 research by making its clinical research platform available…

Read more

Innovative X-ray imaging shows Covid-19 can cause vascular damage to the heart

An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH) has detected significant changes in the heart…

Read more

40 percent of those who have recovered from COVID-19 suffer from long covid symptoms

Not much is known about Long Covid. A new study by the Mainz University Medical Center shows that around 40 per cent struggle with health problems for…

Read more

New DZHK study to reduce scarring in narrowed heart valves

Despite successful treatment of narrowed aortic valves by catheter-assisted aortic valve implantation (TAVI), patients with severely scarred hearts…

Read more

Use of certain antibodies in patients with cardiogenic shock shows no benefit in clinical trial

The treatment of patients with the antibody Adrecizumab after cardiogenic shock has no clinical benefit. Promising results from previous studies could…

Read more